DESCRIPTION (provided by applicant): The pituitary hormone prolactin (PRL) stimulates the growth and differentiation of many tissues and cell types. To understand a role of PRL in mitogenic signaling, we isolated a number of immediate early genes activated after PRL stimulation. One such gene, NudC, was cloned as an early growth response gene. Genetic, biochemical and cellular studies show that NudC associates with the microtubule (MT)-dependent dynein/dynactin motor complex that mediates many mitotic processes. Our studies suggest that NudC plays multiple roles in mitosis (nuclear division) and cytokinesis (cytoplasmic division). We showed that altering NudC levels by either small interference RNA (siRNA)-mediated gene silencing or adenovirus-mediated overexpression resulted in defects in cytokinesis, as reflected by an increase in the number of multinucleated cells and cells with persistent intercellular connections. MTs in the midzone and midbody matrix appeared disorganized, providing a possible clue on a cytokinesis defect. In addition, we show that NudC is a mitotic phosphoprotein and it interacts with the mitotic kinase polo-like kinase 1 (Plkl), suggesting that NudC phosphorylation may affect NudC functions during mitosis. We hypothesize that a precise level and phosphorylation state of NudC are required for mitotic progression and completion of cytokinesis, and that NudC functions by regulating the dynein/dynactin complex and MT dynamics during mitosis and cytokinesis. To delineate NudC functions in mitogenic signaling, we propose to 1) Determine NudC function in mitosis and cytokinesis by analyzing how changes in NudC levels and phosphorylation state affect mitosis progression and completion of cytokinesis, and to 2) Analyze regulation of dynein/dynactin by NudC by addressing how NudC regulates dynein complex stability and MT dynamics. These studies should contribute to a fundamental understanding of the mechanisms of PRL-mediated mitogenic signaling.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
051113330
UEI
FXKMA43NTV21
Project Start Date
15-March-1998
Project End Date
31-March-2008
Budget Start Date
01-April-2004
Budget End Date
31-March-2005
Project Funding Information for 2004
Total Funding
$292,657
Direct Costs
$198,000
Indirect Costs
$94,657
Year
Funding IC
FY Total Cost by IC
2004
National Institute of Diabetes and Digestive and Kidney Diseases
$292,657
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R01DK053176-05A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01DK053176-05A1
Patents
No Patents information available for 2R01DK053176-05A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01DK053176-05A1
Clinical Studies
No Clinical Studies information available for 2R01DK053176-05A1
News and More
Related News Releases
No news release information available for 2R01DK053176-05A1
History
No Historical information available for 2R01DK053176-05A1
Similar Projects
No Similar Projects information available for 2R01DK053176-05A1